อ้างอิง ของ Gam-COVID-Vac

  1. "Sputnik V". Russian drug reference. Medum.ru.
  2. 1 2 3 Callaway E (August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature. 584 (7821): 334–335. doi:10.1038/d41586-020-02386-2. PMID 32782400. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.
  3. 1 2 Cohen J (11 August 2020). "Russia's approval of a COVID-19 vaccine is less than meets the press release". Science. สืบค้นเมื่อ 13 August 2020.
  4. 1 2 Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, และคณะ (2021-02-02). "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia". The Lancet. doi:10.1016/s0140-6736(21)00234-8.
  5. 1 2 Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, และคณะ (September 2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". Lancet. 396 (10255): 887–897. doi:10.1016/S0140-6736(20)31866-3. PMC 7471804. PMID 32896291.
  6. Mahase E (August 2020). "Covid-19: Russia approves vaccine without large scale testing or published results". BMJ. 370: m3205. doi:10.1136/bmj.m3205. PMID 32816758.
  7. Burki TK (November 2020). "The Russian vaccine for COVID-19". The Lancet. Respiratory Medicine. 8 (11): e85–e86. doi:10.1016/S2213-2600(20)30402-1. PMID 32896274.
  8. Berkeley Jr L (11 August 2020). "Scientists worry whether Russia's Sputnik V' coronavirus vaccine is safe and effective". CNBC (ภาษาอังกฤษ). สืบค้นเมื่อ 11 August 2020.
  9. 1 2 Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, และคณะ (September 2020). "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia". Lancet. 396 (10255): 887–897. doi:10.1016/S0140-6736(20)31866-3. PMID 32896291.
  10. 1 2 "An Open Study of the Safety, Tolerability and Immunogenicity of the Drug 'Gam-COVID-Vac' Vaccine Against COVID-19". ClinicalTrials.gov. 22 June 2020.
  11. "Coronavirus Vaccine Trials Advance in Race for Covid-19 Protection" (ภาษาอังกฤษ). Bloomberg. สืบค้นเมื่อ 2020-08-10.
  12. "Russia's RDIF & Prominent Government Lab Progress COVID-19 Vaccine: Production Facility Readied in the Moscow Region". trialsitenews.com (ภาษาอังกฤษ). June 10, 2020. สืบค้นเมื่อ 2020-08-11.
  13. Sokolov A (December 12, 2020). "Сколько хотят заработать на прививках от коронавируса". Vedomosti. คลังข้อมูลเก่า เก็บจาก แหล่งเดิม เมื่อ 2020-08-12. สืบค้นเมื่อ 2020-12-20.
  14. "Нормативная документация ЛП-006395-110820" (PDF) (ภาษารัสเซีย). Russian Ministry of Health. 2020. สืบค้นเมื่อ 2020-09-21.
  15. "Центр Гамалеи назвал сроки вакцинации большей части населения России". RBK. September 4, 2020. สืบค้นเมื่อ 2020-09-06.
  16. Sagdiev R, Ivanova P, Nikolskaya P, Swift R, Smout A (17 November 2020). Mason J, Macfie N (บ.ก.). "Russia focuses on freeze-dried vaccine doses as transport fix". Reuters. Moscow. สืบค้นเมื่อ 20 November 2020.
  17. Ellyatt H (2020-09-10). "Scientists question 'strange' data in Russian coronavirus vaccine trial after 'unlikely' patterns". CNBC. สืบค้นเมื่อ 2020-09-10.
  18. Logunov DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV (October 2020). "Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors' reply". Lancet. 396 (10256): e54–e55. doi:10.1016/S0140-6736(20)31970-X. PMID 32971043. S2CID 221805026.
  19. "Hadassah bringing 1.5 million doses of Russian COVID-19 vaccine to Israel". The Jerusalem Post | JPost.com (ภาษาอังกฤษ). สืบค้นเมื่อ 2020-11-19.
  20. "Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19" (ภาษาอังกฤษ). National Library of Medicine. สืบค้นเมื่อ 28 September 2020.
  21. "Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus". clinicaltrials.gov (ภาษาอังกฤษ). สืบค้นเมื่อ 2021-01-14.
  22. "UAE volunteers receive Russian Covid-19 vaccine". Khaleej Times. January 10, 2021.
  23. Bharadwaj S (January 15, 2021). "Dr Reddy's gets DCGI nod for Covid-19 vaccine Sputnik V Phase III trials". The Times Of India.
  24. Clinical trial number NCT04642339 for "Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela" at ClinicalTrials.gov
  25. Logunov, Denis (2021-02-02). "Sputnik V COVID-19 vaccine candidate appears safe and effective". The Lancet. doi:10.1016/S0140-6736(21)00234-8.
  26. "Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests". The Guardian. February 2, 2021. สืบค้นเมื่อ 2021-02-06.